Effect of maerua subcordata (Gilg) DeWolf extracts on blood glucose level in rodents
Tanzania Journal of Health Research · 07.09.2025 · 26 (5) · 2645-2674
DOI: 10.4314/thrb.v26i5.20s ↗Kurz gefasst
Fachartikel in der Zeitschrift Tanzania Journal of Health Research, online erschienen am 07.09.2025. Verfasst von Mebrahtom Gebrelibanos Hiben und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Maerua subcordata is used as a herbal medicine for the management of diabetes, among others. This study aimed to evaluate the safety and effects on blood glucose level (BGL) of M. subcordata extracts using a rodent model.
Methods
The leaf and root extracts were first evaluated using STZ-induced diabetic Swiss albino mice at doses of 250 and 500 mg/kg body weight. Then the fruit, leaf, root and seed extracts were studied using normoglycemic, glucose-challenged, and STZ-nicotinamide induced diabetic SD rats at a dose of 300 mg/kg body weight. Results: acute toxicity studies at 2g/kg revealed no obvious toxicity signs. Leaf extract exhibited a considerable fasting BGL-lowering effect in normoglycemic, glucose-challenged, and STZ-nicotinamide induced diabetic SD rats and STZ-induced diabetic mice that were comparable to glibenclamide and metformin. The root extract enhanced BGL in normoglycemic and glucose-challenged rats but displayed milder anti-diabetic activity in STZ-nicotinamide induced diabetic rats and appreciable anti-diabetic activity in STZ-induced diabetic mice, with the lower dose showing higher activity. The fruit and seed extracts enhanced glycaemia in normoglycemic but controlled glycaemia in glucose-challenged rats, implying these extracts may control postprandial hyperglycemia.
Conclusion
M. subcordata leaf extract revealed significant and dose-dependent glycaemia-lowering effect in different rodent models, while the root extract showed inconsistent antidiabetic activity, both in terms of dose and rodent type. The fruit and seed extracts showed postprandial hyperglycemia-controlling potential. Accordingly, verified, optimised, and standardized botanical preparation may be suggested, expecting potential health benefits, including the management of diabetes.
Zitieren
APA
Hiben, M. G., Manasib, T. A., Tareke, H. B., Tekulu, G. H., Tsegay, A. T., Kassegn, H. H., Kalayu, T. H., & Asfaw, Y. T. (2025). Effect of maerua subcordata (Gilg) DeWolf extracts on blood glucose level in rodents. Tanzania Journal of Health Research, 26(5), 2645-2674. https://doi.org/10.4314/thrb.v26i5.20s
Vancouver
Hiben MG, Manasib TA, Tareke HB, Tekulu GH, Tsegay AT, Kassegn HH, et al. Effect of maerua subcordata (Gilg) DeWolf extracts on blood glucose level in rodents. Tanzania Journal of Health Research. 2025;26(5):2645-2674. doi:10.4314/thrb.v26i5.20s
BibTeX
@article{Hiben2025,
author = {Hiben, Mebrahtom Gebrelibanos and Manasib, Tilahun Arefe and Tareke, Helen Bitew and Tekulu, Gebretsadkan Hintsa and Tsegay, Amanueal Tesfay and Kassegn, Hagos Hailu and Kalayu, Tesfay Haile and Asfaw, Yohannes Tekle},
title = {Effect of maerua subcordata (Gilg) DeWolf extracts on blood glucose level in rodents},
journal = {Tanzania Journal of Health Research},
year = {2025},
volume = {26},
number = {5},
pages = {2645--2674},
doi = {10.4314/thrb.v26i5.20s}
}
EUVIMED